JUN 07, 2020 8:42 PM PDT

Repurposing An Antibiotic To Defeat a Deadly Superbug

WRITTEN BY: Nouran Amin

A recent study published in Nature Microbiology describes how an old antibiotic used for Tuberculosis can be powerful treatment for a deadly superbug. The re-purposed antibiotic is Rifabutin and was shown to be powerfully active in fighting the multidrug-resistant Acinetobacter baumannii. The particular bacterium has been known to cause life-threatening emergencies according to study experts.

Learn more about the bacterium:

"Rifabutin has been around for more than 35 years, and no one has ever studied it for Acinetobacter infections before," said first author Brian Luna, assistant professor of molecular microbiology and immunology at Keck School of Medicine of USC. "Going forward, we may find many new antibiotics that have been missed over the last 80 years because the screening tests used to discover them were suboptimal."

According to the World Health Organization, Rifabutin is an ‘essential’ medicine and was heavily used for treating TB amongst HIV/AIDS populations who could not receive rifampin.

"Rifabutin can be used immediately to treat such infections because it is already FDA-approved, cheap and generic, and on the market," adds Brad Spellberg, the chief medical officer at the Los Angeles County-University of Southern California Medical Center and senior author of the study. "But we would like to see randomized controlled human trials to prove its efficacy, so we know for sure one way or the other."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 22, 2020
Drug Discovery & Development
New Treatment for Mouth-Hand-Foot Disease
SEP 22, 2020
New Treatment for Mouth-Hand-Foot Disease
A study appearing next week in the journal Nature Communications offers some good news in the search for antiviral drugs ...
OCT 21, 2020
Drug Discovery & Development
New ALS Treatment Extends Life for Several Months
OCT 21, 2020
New ALS Treatment Extends Life for Several Months
Currently, there are only two approved medications to treat Lou Gehrig's disease (also known as ALS), a condition po ...
OCT 01, 2020
Drug Discovery & Development
Antidepressants Treats Lazy Eye
OCT 01, 2020
Antidepressants Treats Lazy Eye
A study published in Current Biology revealed how a therapeutic used as an antidepressant and for managing pain could tr ...
OCT 20, 2020
Drug Discovery & Development
The Power of Extracellular Vesicles
OCT 20, 2020
The Power of Extracellular Vesicles
What are extracellular vesicles (EVs)? They are tiny nanometer sized messengers that transport themselves between cells ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 23, 2020
Drug Discovery & Development
Therapeutically Active Ion-Channels
NOV 23, 2020
Therapeutically Active Ion-Channels
Therapeutically relevant ion channels have inspired researchers to look into drugs that can regulate their activity. Ion ...
Loading Comments...